The shot marks the first time an older, protein-based shot has been approved to fight Covid-19 and the first vaccine Novavax has been able to bring to market in its 34-year history.
The shot marks the first time an older, protein-based shot has been approved to fight Covid-19 and the first vaccine Novavax has been able to bring to market in its 34-year history.